CDK4 as a phytochemical based anticancer drug target
The success story of plant-based medicine has been overlooked during the advent of the modern pharmaceutical industry. Despite the negligence of the multibillion-dollar drug industry, people entirely rely on medicinal plants in some parts of the world. In this study, we have emphasized going back to...
Main Authors: | M. Arif Ashraf, Shomoita Sayed, Martiniano Bello, Nazmul Hussain, Rony Kumer Chando, Saruar Alam, Md. Kamrul Hasan |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-01-01
|
Series: | Informatics in Medicine Unlocked |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2352914821002896 |
Similar Items
-
MPDB 2.0: a large scale and integrated medicinal plant database of Bangladesh
by: Nazmul Hussain, et al.
Published: (2021-08-01) -
Lead phytochemicals for anticancer drug development
by: Sukhdev Singh, et al.
Published: (2016-11-01) -
Efforts in Bioprospecting Research: A Survey of Novel Anticancer Phytochemicals Reported in the Last Decade
by: Saheed O. Anifowose, et al.
Published: (2022-11-01) -
Codelivery of Phytochemicals with Conventional Anticancer Drugs in Form of Nanocarriers
by: Girish Kumar, et al.
Published: (2023-03-01) -
Anticancer screening of medicinal plant phytochemicals against Cyclin-Dependent Kinase-2 (CDK2): An in-silico approach
by: Wajahat Khan, et al.
Published: (2017-08-01)